Clinical Research Directory
Browse clinical research sites, groups, and studies.
Early Automated Insulin Delivery (AID) Pilot for Newly Diagnosed T1D
Sponsor: Stanford University
Summary
Type 1 diabetes is a common chronic medical condition among youth in the US that requires intensive glycemic management to prevent long-term morbidity and mortality. Current pediatric diabetes care in the US underutilizes automated insulin delivery (AID) systems, which are the best available tools for promoting tight glycemic control while reducing user burden. This proposal aims to support early and sustained use of AID systems by examining and optimizing conditions, evaluating glycemic outcomes, and identifying contextual facilitators and barriers of implementation.
Official title: Early AID Pilot for Newly Diagnosed T1D
Key Details
Gender
All
Age Range
2 Years - 26 Years
Study Type
INTERVENTIONAL
Enrollment
16
Start Date
2026-03
Completion Date
2031-03
Last Updated
2026-03-30
Healthy Volunteers
No
Conditions
Interventions
Tandem Automated Insulin Delivery System
Participants will be required to initiate AID system within 2-4 weeks of diabetes diagnosis, use a simplified meal announcement (SMA) strategy for insulin dosing. AID combines a continuous glucose monitor, an insulin pump, and a dosing algorithm to continuously adjust insulin delivery based on current and predicted future glucose levels.
Locations (1)
Stanford Children's
Palo Alto, California, United States